The Food and Drug Administration approved a new Eli Lilly drug this month that treats Alzheimer's disease. Kisunla is an IV ...
(WGN Radio) – A new drug that shows promising results of slowing memory decline recently received the Food and Drug Administration’s stamp of approval – but will anyone be able to afford it? The FDA ...
With the first wave of Alzheimer’s disease drugs reaching the market, investors continue to seek out the next big advance in ...
In a new bid to get insurers to cover popular weight loss medications, one of the companies behind has sponsored studies into ...
The manufacturer of anti-obesity drug Zepbound has asked the FDA to authorize the drug for sleep apnea. Here's why that could ...
Their goal is to raise funds for care and support for Alzheimer’s patients as well as money to research a cure.
Oxford study demonstrates that Novo Nordisk's (NVO) semaglutide is not associated with a risk of adverse neuropsychiatric ...
The case centers on a Form 483, a warning letter the FDA issues if pharmaceutical companies fail ... the timing and ultimate ...
Despite recent concerns about suicidality and other neuropsychiatric issues, a recent study has found that Novo Nordisk’s ...
Advisors recount their successes of the first half, as well as their misses, because nobody at the track trusts a guy that ...
After nearly 20 years of research, a breakthrough in the fight against Alzheimer's may have been discovered in southeast Texas.The Alzheimer's Association said the crippling neurological disease ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.